Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
CBT 200 Gains 62 Points. More details...
An Additional $19 Million To Top Off The Year. More...
Wrapup Of The Big Kahuna Confab. More details...
Including Private and Public Companies. More details...
Biotech Makes A Big Gain. More details...
CBT 200 Gives Back Half Of Monday's Gain. More details...
CBT 200 Down 34 Points In Late Slide. More details...
Biogen Idec/Elan Drug Faces Advisory Committee. More...
Company Markets Plasma Products. More details...
CBT 200 Gains 1.4%. More details...
Upcoming Events
BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here
Register here
Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events
Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here